Ozempic vs Wegovy: Same Drug, Different Purpose

Here’s the fact that surprises most people: Ozempic and Wegovy are the same medication (semaglutide), just sold under different brand names, at different doses, for different approved uses. Ozempic is approved for type 2 diabetes; Wegovy is approved for weight management. So if your goal is weight loss, Wegovy is the on-label version, though the underlying drug is identical. Here’s what actually separates them and why two brands exist.

Why One Drug Has Two Names

It comes down to how drugs get approved. Novo Nordisk developed semaglutide and first brought it to market as Ozempic for type 2 diabetes. When trials showed it also produced substantial weight loss, the company sought a separate approval for obesity and branded that version Wegovy, at a higher maximum dose. Same molecule, two brands, two sets of approved uses. This is why you’ll hear the drugs discussed almost interchangeably, even though they’re marketed differently.

Head to Head

The Dose Difference

The doses differ slightly. Ozempic goes up to 2 mg weekly, while Wegovy goes up to 2.4 mg (with an even higher 7.2 mg option added recently). Since weight loss is dose-dependent, the weight-management version is dosed to maximize that effect. In practice, at comparable doses the weight loss is similar, because it’s the same drug, but Wegovy is specifically titrated and approved for obesity. Consider a hypothetical patient who hears friends rave about “Ozempic for weight loss”: they’re really describing semaglutide’s effect, which Wegovy delivers as the approved weight-management product.

Approved Uses Are Diverging

Over time, the two brands have picked up different additional approvals. Semaglutide’s landmark cardiovascular trial, published in the New England Journal of Medicine as part of the broader STEP obesity program in 2021 and followed by dedicated heart-outcome studies, established benefits that now support cardiovascular indications for both brands in their respective populations. More recently, Wegovy gained an approval for MASH (a fatty liver disease) and is now available as an oral tablet, expanding its uses beyond Ozempic’s. So while the drug is the same, the brands are increasingly used for different things.

Which Should You Use for Weight Loss?

For weight management specifically, Wegovy is the appropriate, approved choice, dosed and indicated for it. Ozempic is approved for diabetes, and while it contains the same drug, using it purely for weight loss would be off-label. That distinction matters for prescribing and insurance. A provider can determine which brand fits your situation, especially if you have both diabetes and weight to address.

What This Means for You Right Now

Both Ozempic and Wegovy are available, and both are among the brand options TrimRx offers, alongside compounded semaglutide. That means whether your goal is weight management, diabetes care, or both, a provider can help match you to the right semaglutide product for your needs.

Frequently Asked Questions

Are Ozempic and Wegovy the same thing?

They contain the same drug, semaglutide, but are different brands with different approved uses and doses. Ozempic is approved for type 2 diabetes; Wegovy is approved for weight management (at a slightly higher maximum dose).

Can I use Ozempic for weight loss?

Ozempic contains the same drug as Wegovy, but it’s approved for diabetes, so using it for weight loss would be off-label. Wegovy is the version specifically dosed and approved for weight management. A provider can advise on the right choice.

Which produces more weight loss?

At comparable doses, the weight loss is similar because it’s the same drug. Wegovy is dosed slightly higher and approved for weight management, so it’s the appropriate choice for that goal.

To find the right fit, you can check what you’re eligible for with a licensed provider.

This information is for educational purposes and is not medical advice. Consult a healthcare provider before starting any medication. Individual results may vary.